JoanLWalkerMD

Obstetrics & Gynecology • Oklahoma City, OK

Gynecologic Oncology, Hospice & Palliative Medicine

Associate Professor of Obstetrics & Gynecology, University Okla College of Medicine

Join to view full profile

Dr. Walker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Walker's full profile

Already have an account?

Office
825 NE 10th St
# OUPB5200
Oklahoma City, OK 73104
Phone+1 405-271-7770

Education & Training

University of California (Irvine)Fellowship, Gynecologic Oncology, 1988 - 1990
University of California (Irvine)Residency, Gynecologic Oncology, 1986 - 1990
University of California (Irvine)Fellowship, Gynecologic Oncology, 1986 - 1987
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1982 - 1986
David Geffen School of Medicine at UCLAClass of 1982

Certifications & Licensure

OK State Medical License 1990 - 2025
CA State Medical License 1985 - 2020
PA State Medical License 1984 - 2004
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus Start of enrollment: 1996 Apr 01
Completed
Phase 3
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix Start of enrollment: 1999 Nov 01
Completed
Phase 1
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Start of enrollment: 1999 Nov 01
Completed
Phase 1, Phase 2
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) Start of enrollment: 2004 May 01
Completed
Phase 1
Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma Start of enrollment: 2006 Jan 01
Terminated
Phase 2
Laparoscopic Approach to Cervical Cancer Start of enrollment: 2008 Jan 01
Completed
Not Applicable
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2009 Aug 11
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker
Journal of Clinical Oncology. 2024-07-20
1 citations
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncol...
Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, Neil T Phippen, Christopher M Tarney
Gynecologic Oncology. 2024-04-01
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
John K Chan, Chunqiao Tian, Joshua P Kesterson, Ken Y Lin, Kathleen Darcy
Gynecologic Oncology. 2024-02-01

Press Mentions

Stephenson Cancer Center Gets 2.2 Million Grant to Fund Cervical Cancer PreventionJune 22nd, 2016

Grant Support

Expression Of MN Protein In Agcus As Potential Biomarker Of Dysplasia/NeoplasiaNational Center For Research Resources2004–2006
A Study To Understand Cervical Cancer Early Endpoints And Determinants (SUCCEED)National Center For Research Resources2005
Prevalence Of Symptoms Suggestive Of Ovarian CancerNational Center For Research Resources2004–2005
Outcomes In Gynecologic CancerNational Center For Research Resources2004–2005
Study To Understand Cervical Cancer Early Endpoints AnNational Center For Research Resources2004
Pivotal Study II: Single-Arm Multi-Ctr. Study Of ODS As Adjunct To ColposcopyNational Center For Research Resources2004

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow
American College of Surgeons - ACS
Member